Combination of gemox, lenvatinib, and PD-1 blockade vs. gemox monotherapy as first-line treatment for intrahepatic cholangiocarcinoma with metastases.
10.1097/CM9.0000000000003765
- Author:
Wenjing ZHANG
1
;
Wei LIANG
2
;
Hongji YOU
3
;
Yali LI
2
;
Qinqiu HE
2
;
Wang WEI
4
;
Qunfang ZHOU
2
;
Fei TUO
5
Author Information
1. Department of Ultrasound, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510260, China.
2. Department of Minimally Invasive Interventional Radiology, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510260, China.
3. Department of Nuclear Medicine, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510260, China.
4. Department of General Surgery, the First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning 121000, China.
5. Department of Ultrasound Diagnose, the First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan 410208, China.
- Publication Type:Journal Article
- From:
Chinese Medical Journal
2025;138(22):3007-3009
- CountryChina
- Language:English
